Showing results (1-10 of 85) with videos related to
Sort By:
Pageof 9
Nederlands Tijdschrift Voor Geneeskunde|October 30, 2024
[Redispensing of expensive oral anticancer medicines: a practical application]Lisanne N van Merendonk, Kübra Akgöl, Bastiaan NuijenInternational Journal of Pharmaceutics|June 25, 2013
Long term stability of lyophilized plasmid DNA pDERMATTIris van der Heijden, Jos H Beijnen, Bastiaan NuijenJournal of Pharmaceutical and Biomedical Analysis|October 18, 2017
Thermal stability study of crystalline and novel spray-dried amorphous nilotinib hydrochlorideMaikel Herbrink, Herman Vromans, Jan Schellens, et al.International Journal of Pharmaceutics|December 11, 2012
Slow dissolution behaviour of amorphous capecitabineJelte Meulenaar, Jos H Beijnen, Jan H M Schellens, et al.Pharmaceutical Research|June 1, 2017
High-Tech Drugs in Creaky FormulationsMaikel Herbrink, Bastiaan Nuijen, Jan H M Schellens, et al.Cancer Treatment Reviews|March 31, 2015
Variability in bioavailability of small molecular tyrosine kinase inhibitorsMaikel Herbrink, Bastiaan Nuijen, Jan H M Schellens, et al.International Journal of Pharmaceutics|August 3, 2016
Pharmaceutical development of an oral tablet formulation containing a spray dried amorphous solid dispersion of docetaxel or paclitaxelEmilia Sawicki, Jos H Beijnen, Jan H M Schellens, et al.International Journal of Pharmaceutics|July 11, 2017
Improving the solubility of nilotinib through novel spray-dried solid dispersionsMaikel Herbrink, Jan H M Schellens, Jos H Beijnen, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|June 4, 2019
Use of leftovers of monoclonal antibody products after partial extraction - A microbiological safety studyA Hedvig Arnamo, Alwin Dr Huitema, Jos H Beijnen, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|May 12, 2021
Stability study of concentrate-solvent mixture & infusion solutions of Jevtana® cabazitaxel for extended multi-dosingA Hedvig Arnamo, Alwin D R Huitema, Jos H Beijnen, et al.Pageof 9